Accumulation of 1-methyl-tetrahydro-Β-carboline-3-carboxylic acid in blood and organs of rat. A possible causative substance of eosinophilia-myalgia syndrome associated with ingestion ofl-tryptophan
- 1 May 1993
- journal article
- Published by Springer Nature in Archives of Toxicology
- Vol. 67 (4) , 290-293
- https://doi.org/10.1007/bf01974349
Abstract
1-Methyl-tetrahydro-Β-carboline-3-carboxylic acid (MTCA) may cause eosinophilia-myalgia syndrome (EMS) associated with ingestion ofl-tryptophan. The distribution and excretion of MTCA were studied in rats which had received perorally a single 1.6 mg/kg dose of MTCA. MTCA concentrations in blood, kidney, liver, brain, heart, spleen, lung and gastrocnemius muscle were measured by HPLC combined with fluorometric detection. The concentration of MTCA in each organ reached a maximum at 1 h and then gradually declined. However, a significant level of MTCA still remained at 5 h, when 52% of ingested MTCA remained in the contents of the large intestine. Twenty-nine percent of the ingested MTCA was excreted in urine over the course of 24 h. A higher dose (10 mg/kg) of MTCA resulted in significant elevations in the concentrations and amounts of MTCA in the various organs. In addition, chronic treatment with a 10 mg/kg dose of MTCA for 6 weeks further increased the concentrations and amounts of MTCA in each organ. However, no histological changes were observed in any of the organs after chronic treatment. This is the first report which demonstrates accumulation of MTCA in the blood and various organs, including muscle, of rats.Keywords
This publication has 14 references indexed in Scilit:
- Identification of substances formed by decomposition of peak E substance in tryptophanFood and Chemical Toxicology, 1992
- Excretion and distribution of nitrite-treated or untreated 1-methyl-1,2,3,4-tetrahydro-β-carboline-3-carboxylic acid in ratsFood and Chemical Toxicology, 1991
- Endogenous formation of 1-methyl-1,2,3,4-tetrahydro-β-carboline-3-carboxylic acid in man as the possible causative substance of eosinophilia-myalgia syndrome associated with ingestion ofl-tryptophanArchives of Toxicology, 1991
- Effect of synthesized constituents in the L-tryptophan product on the differentiation of eosinophils and the induction of IL-6: A possible cause of eosinophilia-myalgia syndromeBiochemical and Biophysical Research Communications, 1991
- Characterization of "Peak E," a Novel Amino Acid Associated with Eosinophilia-Myalgia SyndromeScience, 1990
- L-tryptophan implicated in human eosinophilia-myalgia syndrome causes fasciitis and perimyositis in the Lewis rat.Journal of Clinical Investigation, 1990
- The Cause of the Eosinophilia–Myalgia Syndrome Associated with Tryptophan UseNew England Journal of Medicine, 1990
- An Investigation of the Cause of the Eosinophilia–Myalgia Syndrome Associated with Tryptophan UseNew England Journal of Medicine, 1990
- Scleroderma, Fasciitis, and Eosinophilia Associated with the Ingestion of TryptophanNew England Journal of Medicine, 1990
- Alkaloids in mammalian tissues. 3. Condensation of L-tryptophan and L-5-hydroxytryptophan with formaldehyde and acetaldehydeJournal of Medicinal Chemistry, 1973